Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recommended
How to apply for FEMA assistance after Helene
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Beam Therapeutics Inc
(NQ:
BEAM
)
23.47
+0.06 (+0.26%)
Streaming Delayed Price
Updated: 10:40 AM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beam Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Beam Therapeutics Stock: Bear vs. Bull
October 21, 2023
This biotech has a few factors in its corner, but it also faces a difficult path.
Via
The Motley Fool
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 19, 2023
Gainers
Via
Benzinga
Investors Unpack Home Sales Data Ahead Of Fed Speech
October 19, 2023
Stocks are lower across the board, as investors unpack this morning's jobs and manufacturing data and await commentary from Federal Reserve Chairman Jerome Powell.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
What's Going On With Beam Therapeutics Stock Thursday?
October 19, 2023
Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading lower Thursday.
Via
Benzinga
Analyst Expectations for Beam Therapeutics's Future
October 17, 2023
Via
Benzinga
2 Cathie Wood Stocks I'm Bullish On
October 05, 2023
These two next-gen biotechs could be outstanding buys for patient investors.
Via
The Motley Fool
Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline
October 19, 2023
From
Beam Therapeutics
Via
GlobeNewswire
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.
Via
InvestorPlace
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
Both are in a race against time to commercialize a medicine before cash runs out.
Via
The Motley Fool
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
October 03, 2023
The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome.
Via
The Motley Fool
4 Analysts Have This to Say About Beam Therapeutics
August 29, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
October 02, 2023
On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
September 29, 2023
The iconic money manager has struggled the last two months. Let's see what she's buying to get back on track.
Via
The Motley Fool
Cathie Wood's Ark Invest Tweaks Portfolio, Sells $1.8M Worth Of DraftKings Shares
September 28, 2023
Via
Benzinga
2 Magnificent Growth Stocks to Buy On the Dip
September 27, 2023
It might be time to catch these falling knives.
Via
The Motley Fool
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
September 22, 2023
Cathie Wood is loading up on these healthcare stocks.
Via
The Motley Fool
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
September 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.
Via
The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
September 17, 2023
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good.
Via
The Motley Fool
This Cathie Wood Stock Is Down 40% in 2023. Here's Why She's Still Buying It.
September 08, 2023
The decline of Beam's stock says little about its long-term potential, according to Wood.
Via
The Motley Fool
Cathie Wood's Buying These 3 Stocks Hand Over Fist
September 08, 2023
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
Via
The Motley Fool
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
September 07, 2023
First Preclinical Data for BEAM-302 Demonstrate Increased Levels of Corrected AAT and Reduced Mutant PiZ AAT in Multiple In Vivo Rodent Disease Models
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood's Ark Invest Keeps Shedding Shopify Nvidia Shares, Loads Up On Spotify Stock
September 05, 2023
Via
Benzinga
Beam Therapeutics' Role In Gene-Editing 2.0 Revolution: First U.S. Patient Treated With Base-Edited Cell Therapy
September 05, 2023
Beam Therapeutics Inc (NASDAQ: BEAM) announced that in August, the first patient was treated with BEAM-201, a quadruplex-edited allogeneic
Via
Benzinga
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 05, 2023
BEAM-201 Represents First Quadruplex-edited, Allogeneic CAR-T Cell Therapy Candidate in Clinical-stage Development and First Treatment with a Base Editing Candidate in United States
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics to Participate in Upcoming September Investor Conferences
August 31, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Why Is Apellis Pharmaceuticals Stock Trading Lower Today?
August 29, 2023
Apellis Pharmaceuticals Inc (NASDAQ: APLS) revealed a comprehensive corporate restructuring plan aimed at catalyzing the growth of its flagship products, Syfovre (pegcetacoplan injection) and
Via
Benzinga
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
August 26, 2023
These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.
Via
The Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
August 19, 2023
There's no guarantee that any stock will deliver 2 times returns. But the chances for these stocks look pretty good.
Via
The Motley Fool
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
August 15, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
August 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.